Accordingly, liquid biopsy analysis comparing cfDNA from AH and plasma revealed a somatic RB1 splice-site variant c.1498+2T>C with a VAF of 98.5% (Figure 3) only in AH, suggesting tumor biallelic inactivation. The gene discussed is RB1; the disease is neoplasm.